Drug Tariffs Impact - Search News

News

Trump on US tariff deal with India

Trump tariffs live updates: Trump signals drug tariffs may come by Aug. 1, announces deal with Indonesia

President Trump has flagged that US tariffs on pharmaceutical imports are likely to kick in on Aug. 1, with duties on semiconductors also in line for implementation then too. “Probably at the end of the month,

Bloomberg on MSN · 2d

Trump Says Drug Tariffs Probable by Aug. 1, Downplays More Deals

President Donald Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month and that levies on semiconductors could come soon as well, suggesting that those import taxes could hit alongside broad “reciprocal” rates set for implementation on Aug.

The Irish Times · 1d

Trump says drug and chip tariffs are likely by August 1st

Additional threat certain to alarm Government already working with EU to reduce impact of threatened 30% general tariff on exports to US

Johnson & Johnson shrugs off tariff impact

Financial Times · 1d

Johnson & Johnson shrugs off tariff impact and forecasts sales boost

In the second quarter, J&J’s worldwide oncology sales shot up more than 20 per cent, offsetting declines in sales of its popular immune system medicine Stelara, which is facing a patent cliff. Sales in its smaller, medtech division increased 6 per cent.

Reuters on MSN · 1d

Johnson & Johnson lifts 2025 forecast, halves tariff cost outlook

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and profit forecast on Wednesday after a strong quarter for flagship cancer drug Darzalex and its cardiovascular devices.

MarketWatch on MSN · 1d

Johnson & Johnson’s stock surges as tariff cost estimate slashed and profit outlook raised

Johnson & Johnson has slashed on Wednesday its estimate for the impact of tariffs in 2025, which it now expects to be around $200 million. The company’s stock is climbing in morning trading, boosted by better-than-expected second-quarter results and raised outlook,

Bloomberg on MSN7h

Novartis CEO on Psoriasis Drug, China Growth, Tariffs, M&A

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

8hon MSN

Novartis CEO: Tariffs are an overhang on the pharmaceutical sector

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

BioSpace12h

Novartis ‘Moving as Fast as Possible’ to Fully Manufacture Key Drugs in US as Tariffs Near

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

5hon MSN

Trump's Latest Tariff Could Cause Medicine Shortages, Experts Say

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

STAT1d

Pharmalittle: We’re reading about Trump and pharma tariffs, an abortion pill ruling, and more

President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a "low ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results